MICROSATELLITE STABLE COLORECTAL CANCER
Clinical trials for MICROSATELLITE STABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE STABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MICROSATELLITE STABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug combo enters first human tests
Disease control OngoingThis is an early-stage study testing a new drug called DKY709, both alone and combined with another drug (PDR001), in adults with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find safe doses and understand side effects. Researcher…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Radiation and immune drugs team up to fight tough cancers
Disease control OngoingThis study is testing whether combining two immunotherapy drugs (nivolumab and ipilimumab) with targeted radiation can help control advanced colorectal or pancreatic cancer. The goal is to see if this three-part approach can help the body's own immune system better recognize and …
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New drug cocktail tested for Tough-to-Treat colon cancer
Disease control TerminatedThis study is testing whether a combination of four drugs can help control advanced colorectal cancer that has stopped responding to standard treatments. It is for adults with a specific type of cancer called microsatellite stable (MSS) colorectal cancer. The main goals are to se…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC